comparemela.com

Latest Breaking News On - Jamesf benenati - Page 1 : comparemela.com

FDA clears computer-assisted thrombectomy tech from Penumbra

Penumbra (NYSE:PEN) announced today that it received FDA clearance for and began the launch of its Lightning Flash 2.0 CAVT system.

Penumbra addresses limitations of ACS management strategy

Penumbra’s Indigo System CAT RX allows healthcare professionals to remove blood clots from the coronary & peripheral vasculature

Penumbra Launches Indigo System CAT RX Catheter in Europe to Address Acute Coronary Syndrome

Latest technology combines superior catheter design and sustained aspiration to maximize blood clot removal from the coronary vasculature

First patient enrolled in Penumbra thrombectomy study

Penumbra (NYSE:PEN) today announced the first patient enrolled in STORM-PE, a trial of its Lightning Flash thrombectomy system.

Data from VIVA23 Late-breaking Clinical Trial Focuses on Computer-Assisted Vacuum Thrombectomy for Pulmonary Embolism

The latest STRIKE-PE data, presented by Penumbra, Inc. at the Vascular Interventional Advances Conference, VIVA23, showed that computer assisted vacuum thrombectomy (CAVT) for the treatment of pulmonary embolism is safe and effective at reducing right heart strain, and also improved clinical and functional outcomes.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.